Showing 1 posts of 1 posts found.
Targacept and Catalyst Biosciences have signed a merger agreement which will see them develop new treatment options for patients with …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO